SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced a new HPLC-Chip that dramatically simplifies the analysis of phosphopeptides in proteomics research. The Phosphochip is used with Agilent HPLC-Chip/MS instrumentation to identify post-translational modifications (PTMs) as part of regulating biological pathways. This new HPLC-Chip was co-developed with Professor Albert J.R. Heck’s group at Utrecht University as part of the Netherlands Proteomics Centre research program.
